Aldeyra Therapeutics Inc ALDX:NASDAQ

Last Price$3.25NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.22(6.34%)
Bid (Size)$3.22 (1)
Ask (Size)$3.33 (2)
Day Low / High$3.24 - 3.52
Volume915.2 K

Aldeyra Therapeutics Completes Enrollment in Dry Eye Disease Phase 3 Trial

3:34PM ET 11/09/2021 MT Newswires
Aldeyra Therapeutics (ALDX) said Tuesday that it completed enrollment in a phase 3 trial of 0.25% reproxalap ophthalmic solution for the treatment of patients with dry eye disease.

The trial enrolled 300 patients, who were randomized equally to receive either reproxalap or vehicle. The primary endpoint of the trial is ocular redness. The company expects to release top-line results from the trial in this quarter.

Aldeyra expects to submit a new drug application in early 2022.

Price: 9.23, Change: +0.12, Percent Change: +1.32